From March 24-27, the Society of Gynecological Oncology (SGO) hosted its Annual Meeting on Women's Cancer in New Orleans, Louisiana. The meeting brought together gynecologic oncologists from all over the world to learn to share the latest research and practice innovations in the treatment of gynecologic malignancies. Journal of Clinical Pathways offered coverage of the most important abstracts and featured sessions at the conference.
The ASCO Patient-Centered Oncology Payment model helps achieve costs savings in ovarian cancer when hospitalizations are reduced during the active treatment period.
In comparison to the funding and survival rate of many other cancer types, funding for ovarian, cervical, and uterine cancer does not align with their survival rates.
A featured poster session detailed the results of a study comparing the efficacy and tolerability of PARP inhibitors as maintenance treatment in BRCA-mutated platinum-sensitive relapsed ovarian cancer.
Participation in clinical trials may help overcome health disparities in the treatment of advanced or recurrent ovarian cancer.